Ares Financial Consulting’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Ares Financial Consulting's NVO Position: Q3 2026 in Review
Ares Financial Consulting increased its Novo Nordisk (NVO) stake by 17% in Q3 2026, buying an estimated $10.1K and bringing the position to 1,490 shares worth $56.5K. The position accounts for 0.04% of the portfolio, ranked #214.
Ares Financial Consulting first reported a position in NVO in Q1 2026 and has held it in 3 quarters since. The position peaked at $60.9K in Q2 2026. 1,237 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Ares Financial Consulting held 1,490 shares of Novo Nordisk worth $56.5K as of Q3 2026.
- Ares Financial Consulting bought 220 Novo Nordisk shares in Q3 2026, an estimated $10.1K.
- Novo Nordisk made up 0.04% of Ares Financial Consulting's portfolio in Q3 2026, its #214 holding.
- Ares Financial Consulting first reported a position in Novo Nordisk in Q1 2026 and has held it in 3 quarters since.
- Ares Financial Consulting's Novo Nordisk position peaked at $60.9K in Q2 2026.
- 1,237 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.